Allmed Medical Products Co.,Ltd (SHE:002950)
China · Delayed Price · Currency is CNY 9.22
+0.11 (1.21%)
Jul 31, 2026, 3:05 PM CST
SHE:002950 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 518.06 | 967.62 | 585.16 | 397.04 | 522.2 | 678.46 |
Short-Term Investments | - | - | - | 2.14 | - | - |
Trading Asset Securities | 252 | 4.56 | 83.15 | 96.82 | 264.63 | 8.14 |
Cash & Short-Term Investments | 770.06 | 972.18 | 668.32 | 496 | 786.84 | 686.6 |
Cash Growth | -13.70% | 45.47% | 34.74% | -36.96% | 14.60% | -55.35% |
Accounts Receivable | 465.73 | 522.06 | 482.75 | 391.25 | 521.56 | 532.46 |
Other Receivables | 150.46 | 91.74 | 72.76 | 68.01 | 47.38 | 56.58 |
Receivables | 616.19 | 613.79 | 555.51 | 459.26 | 568.94 | 589.04 |
Inventory | 820.08 | 720.3 | 615.27 | 707.21 | 877.33 | 846.63 |
Other Current Assets | 135.93 | 98.69 | 88.72 | 117.08 | 165.85 | 120.83 |
Total Current Assets | 2,342 | 2,405 | 1,928 | 1,780 | 2,399 | 2,243 |
Property, Plant & Equipment | 2,060 | 2,049 | 1,829 | 1,988 | 2,019 | 1,603 |
Long-Term Investments | 1,073 | 718.13 | 898.22 | 905.33 | 824.79 | 758.68 |
Goodwill | 97.94 | 97.94 | 95.3 | 98.09 | 98.09 | 25.99 |
Other Intangible Assets | 220.68 | 225.1 | 182.78 | 202.66 | 213.58 | 234.75 |
Long-Term Accounts Receivable | - | - | - | - | - | 17.05 |
Long-Term Deferred Tax Assets | 79.18 | 82.37 | 49.14 | 56.19 | 48.88 | 64 |
Long-Term Deferred Charges | 14.04 | 12.72 | 6.76 | 7.08 | 4.74 | 1.14 |
Other Long-Term Assets | 15.73 | 16.96 | 69.54 | 46.95 | 139.79 | 57.01 |
Total Assets | 5,903 | 5,607 | 5,059 | 5,084 | 5,748 | 5,005 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 460.93 | 476.22 | 360.87 | 326.1 | 897.32 | 253.86 |
Accrued Expenses | 114.1 | 118.25 | 90.01 | 76.39 | 84.96 | 79.82 |
Short-Term Debt | 564.18 | 595.28 | 494.31 | 749.57 | 792.09 | 1,060 |
Current Portion of Long-Term Debt | 37.42 | 33.6 | 69.11 | 54.2 | 27.15 | 99.09 |
Current Portion of Leases | - | 5.35 | 7.68 | 6.36 | 2.1 | 2.27 |
Current Income Taxes Payable | 33.09 | 33 | 24.54 | 6.29 | 4.93 | 35.28 |
Current Unearned Revenue | 9.05 | 18.15 | 13.02 | 64.84 | 129.32 | 7.8 |
Other Current Liabilities | 50.59 | 49.41 | 48.2 | 41.7 | 129.06 | 100.91 |
Total Current Liabilities | 1,269 | 1,329 | 1,108 | 1,325 | 2,067 | 1,639 |
Long-Term Debt | 364.45 | 114.55 | 89.17 | 146.32 | 111.41 | 127.61 |
Long-Term Leases | 58.35 | 58.79 | 0.43 | 4.61 | 5.37 | 0.6 |
Long-Term Unearned Revenue | 253.5 | 259.47 | 197.51 | 191.94 | 189.68 | 292.17 |
Long-Term Deferred Tax Liabilities | 236.01 | 230.32 | 216.04 | 199.71 | 243.16 | 193.82 |
Other Long-Term Liabilities | - | - | - | 5.32 | - | - |
Total Liabilities | 2,182 | 1,992 | 1,611 | 1,873 | 2,617 | 2,253 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 633.27 | 633.27 | 633.27 | 633.27 | 633.27 | 633.27 |
Additional Paid-In Capital | 580.21 | 580.21 | 580.21 | 565.77 | 565.77 | 564.49 |
Retained Earnings | 2,633 | 2,524 | 2,312 | 1,960 | 1,888 | 1,619 |
Treasury Stock | -148.52 | -148.52 | -97.89 | - | - | - |
Comprehensive Income & Other | -0.13 | 6.36 | 8.96 | 28.1 | 14.32 | -63.63 |
Total Common Equity | 3,698 | 3,595 | 3,437 | 3,187 | 3,101 | 2,753 |
Minority Interest | 24.11 | 19.77 | 11.51 | 23.73 | 29.91 | -0.91 |
Shareholders' Equity | 3,722 | 3,615 | 3,448 | 3,211 | 3,131 | 2,752 |
Total Liabilities & Equity | 5,903 | 5,607 | 5,059 | 5,084 | 5,748 | 5,005 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 1,024 | 807.57 | 660.7 | 961.06 | 938.13 | 1,289 |
Net Cash (Debt) | -254.34 | 164.61 | 7.62 | -465.06 | -151.29 | -602.53 |
Net Cash Growth | - | 2060.49% | - | - | - | - |
Net Cash Per Share | -0.41 | 0.27 | 0.01 | -0.73 | -0.24 | -0.95 |
Filing Date Shares Outstanding | 615.44 | 615.44 | 618.76 | 621.92 | 633.27 | 633.27 |
Total Common Shares Outstanding | 615.44 | 615.44 | 618.76 | 633.27 | 633.27 | 633.27 |
Working Capital | 1,073 | 1,076 | 820.08 | 454.08 | 332.03 | 604.51 |
Book Value Per Share | 6.01 | 5.84 | 5.55 | 5.03 | 4.90 | 4.35 |
Tangible Book Value | 3,379 | 3,272 | 3,158 | 2,886 | 2,789 | 2,492 |
Tangible Book Value Per Share | 5.49 | 5.32 | 5.10 | 4.56 | 4.40 | 3.94 |
Buildings | - | 1,361 | 1,197 | 1,220 | 1,044 | 989.99 |
Machinery | - | 1,902 | 1,879 | 2,044 | 1,679 | 1,534 |
Construction In Progress | - | 199.39 | 27 | 18.35 | 400.62 | 38.24 |